Drug Research
CEPI expands partnership with Clover to rapidly advance development and manufacture of COVID-19 vaccine candidate
CEPI, the Coalition for Epidemic Preparedness Innovations, announced the expansion of its partnership with Sichuan Clover Biopharmaceuticals, Inc to rapidly advance the development and manufacture of Clover’s protein-based COVID-19 S-Trimer vaccine candidate, which is based on Clover’s proprietary Trimer-Tag©...
Press Releases
BD Partners with U.S. Government on $70 Million Manufacturing Infrastructure Project for Mass Vaccination Campaigns
BD, a leading global medical technology company announced the formation of a strategic, public-private partnership with the Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Health and Human Services Office of the Assistant Secretary for Preparedness...
Clinical Trials
ACTC, Eisai & Biogen announce initiation of new phase III clinical study of BAN2401 for preclinical Alzheimer’s disease
The Alzheimer's Clinical Trials Consortium , Eisai Co., Ltd and Biogen Inc announced that a new phase III clinical study (AHEAD 3-45) of BAN2401, an anti-amyloid beta (Aß) protofibril antibody, has been initiated in the United States of America...
Press Releases
Cipla receives final USFDA approval for generic version of Shire’s Firazyr
Cipla Limited announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Icatibant Injectable 30mg/3mL from the United States Food and Drug Administration (US FDA).
Cipla’s Icatibant Injectable Pre-Filled Syringe 30mg/3mL is AP-rated generic version...
Press Releases
Merck Opens its Largest M Lab Collaboration Center in Shanghai
Merck, a leading science and technology company, opened its M LabTM Collaboration Center in Shanghai, the company’s largest of nine centers worldwide.
“With the booming pharmaceutical industry in Asia and greater emphasis on novel drug therapies, we see an increase...
Drug Research
Samsung Biologics and ImmuneOncia sign multi-product development and manufacturing agreement
Samsung Biologics and ImmuneOncia Therapeutics held a signing ceremony for a contract to develop and manufacture five candidate molecules, expanding upon the two companies existing CDO partnership first established in 2018.
“As we already have a track record of successful...
Press Releases
ChargePoint Technology and STERIS collaborate to offer fully validated sterile transfer solution
Powder containment and sterile transfer solutions experts, ChargePoint Technology, announced that it has entered into a collaboration with STERIS, a leading provider of infection prevention and other procedural products and services, to offer a unique and integrated solution for...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read